Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
Scouting for new leadership, prices hikes and successful acquisitions. What’s new for pharma in business?
George A. Chressanthis,
Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...
Nominations are now open for The Medicine Maker 2020 Power List.
John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.
Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?
We are delighted to announce that The Medicine Maker Power List 2019 is here!
The evolving Brexit landscape provides ample opportunities for companies to position themselves as leaders and influencers.
Sitting Down With… Dave Tudor, Managing Director of the Medicines Manufacturing Innovation Centre (MMIC), Scotland, UK.
Research and development tax reliefs are available for businesses in many countries, but some companies are not taking advantage.
Angela Osborne has created her own space in the industry and is helping the cell and gene therapy industry bloom.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.